IP Library Granted Patent US 9,597,349
Granted Patent B2
US 9,597,349 · App. 14/538,482 · Granted Mar 21, 2017

Combination of an oxidant and a photoactivator for the healing of wounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,349
App. No.
14/538,482
Granted
Mar 21, 2017
Kind
B2
Abstract

There is provided a wound healing composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically acceptable carrier. In addition, a method of topically treating wounds using at least one oxidant and at least one photoactivator capable of activating the oxidant followed by illumination of said photosensitizer is disclosed.

Claims (9)

1. A composition which comprises: at least one oxidant, wherein the oxidant is selected from urea peroxide at about 10% to about 16% of the total composition and hydrogen peroxide at about 3.5% to about 6% of the total composition; at least one fluorescent compound; a healing factor selected from the group consisting of hyaluronic acid, glucosamine and allantoin; and a carbomer; in association with a pharmaceutically acceptable carrier.

2. The composition according to claim 1 , which further comprises a gelling agent selected from the group consisting of glucose, modified starch, methyl cellulose, carboxymethyl cellulose, propyl cellulose, hydroxypropyl cellulose, alginic acid, sodium alginate, potassium alginate, ammonium alginate, calcium alginate, agar, carrageenan, locust bean gum, pectin, and gelatin.

3. The composition according to claim 1 , further comprising an additional fluorescent compound selected from the group consisting of a xanthene derivative dye, an azo dye, a biological stain, and a carotenoid.

4. The composition according to claim 1 , wherein said fluorescent compound is eosin Y.

5. The composition according to claim 1 , which further comprises at least one chelating agent selected from the group consisting of ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA).

6. The composition according to claim 1 , which further comprises at least one lipolysis stimulating factor selected from the group consisting of caffeine and paraxanthine.

7. The composition according to claim 1 , which further comprises at least one of rhodamine B, rhodamine WT, rhodamine G, phloxine B, rose bengal, eosin B, fluorescein, erythrosine B, saffranin O, basic fuchsin, acid fuschin, 3,3′ dihexylocarbocyanine iodide, carminic acid, indocyanine green, crocetin, α-crocin (8,8-diapo-8,8-carotenoic acid), zeaxanthine, lycopene, α-carotene, β-carotene, merbromine, bixin, fucoxanthine, methyl violet, neutral red, para red, amaranth, carmoisine, allura red AC, tartrazine, orange G, ponceau 4R, methyl red, murexideammonium purpurate, pyronine Y and pyronine B.

8. The composition according to claim 1 , wherein the composition comprises about 10% to about 16% urea peroxide.

9. The composition according to claim 1 , wherein the composition comprises about 3.5% to about 6% hydrogen peroxide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2023
From: KLOX TECHNOLOGIES INC.
To: FLE INTERNATIONAL S.R.L.
Reel/Frame 063214/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2014
From: PIERGALLINI, REMIGIO; LOUPIS, NIKOLAOS; BELLINI, FRANCESCO
To: KLOX TECHNOLOGIES INC.
Reel/Frame 034393/0728 →